Hangzhou Coco Healthcare Products Co.Ltd. (301009) — Cash Flow-to-Debt Ratio
Hangzhou Coco Healthcare Products Co.Ltd. (301009) has a Cash Flow-to-Debt Ratio of -0.02x as of September 2025, meaning its operating cash flow of CN¥-17.53 Million could theoretically repay 0% of its total liabilities (CN¥739.23 Million) in one year. See Hangzhou Coco Healthcare Products Co.Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hangzhou Coco Healthcare Products Co.Ltd. Cash Flow-to-Debt Ratio (2017–2024)
Historical debt coverage capacity for Hangzhou Coco Healthcare Products Co.Ltd. across 8 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Hangzhou Coco Healthcare Products Co.Ltd.
Annual Cash Flow-to-Debt Ratio for Hangzhou Coco Healthcare Products Co.Ltd. (2017–2024)
Year-by-year debt coverage analysis for Hangzhou Coco Healthcare Products Co.Ltd.. Check Hangzhou Coco Healthcare Products Co.Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.08x | CN¥52.44 Million | CN¥678.06 Million | ▼ -81.6% |
| 2023 | 0.42x | CN¥227.70 Million | CN¥542.40 Million | ▲ +683.2% |
| 2022 | -0.07x | CN¥-37.20 Million | CN¥516.88 Million | ▼ -182.4% |
| 2021 | 0.09x | CN¥50.53 Million | CN¥578.59 Million | ▼ -82.1% |
| 2020 | 0.49x | CN¥395.86 Million | CN¥812.42 Million | ▲ +33.9% |
| 2019 | 0.36x | CN¥223.33 Million | CN¥613.89 Million | ▲ +46.7% |
| 2018 | 0.25x | CN¥114.26 Million | CN¥460.64 Million | ▲ +9.5% |
| 2017 | 0.23x | CN¥109.74 Million | CN¥484.59 Million | — |